Skip to main content
. 2016 Jul 29;3(3):ofw161. doi: 10.1093/ofid/ofw161

Figure 1.

Figure 1.

(A) Comparison of health outcomes according to individual attributes of the viral load testing approach, shown as the difference in disability-adjusted life years (DALYs) incurred compared with dried blood spots (DBS) base scenario. The influence of the attribute is indicated by the range in difference in DALYs incurred for plausible values of the attribute. The DALYS are per 3 months over 20 years from 2017, discounted at 3% per year. (B) Comparison of cost effectiveness according to individual attributes of the viral load testing approach, shown as the difference in net DALYs compared with DBS base scenario. The influence of the attribute is indicated by the range in difference in net DALYs for plausible values of the attribute. ART, antiretroviral therapy.